Dealing with biologics production uncertainty

To better understand demand forecasting challenges, a survey of pharmaceutical and biotechnology industry leaders from North America and Europe was conducted by business intelligence firm ORC International and sponsored by Patheon, a leading global provider of high-quality drug development and […]

Read More

Specialty pharma becomes ‘hub enabled’

In this issue, we return to a topic we’ve covered annually since 2013: hub services. A definition: hub services are usually third-party providers, funded by manufacturers themselves, delivering the range of services necessary to get patients onto specialized (and usually […]

Read More

Pharma logistics–so what?

At Pharmaceutical Commerce, we spent a good bit of time from late autumn into the first few weeks of this year preparing our feature article on global transportation and logistics for life sciences. And, based on which articles were ready […]

Read More

Collaboration key to a healthy supply chain in 2016

Recently, “collaboration” has become a buzzword across the pharmaceutical sector, and certainly within HDMA, as distributors, manufacturers, dispensers and regulators have worked together to ensure that the supply chain operates safely and efficiently to the ultimate benefit of the millions […]

Read More